Raffles Medical Group Ltd
RAFLFOTCHealthcare● Active
$0.80
$-0.01(-0.63%)
Market Cap$1.5B
P/E Ratio—
52W High$0.83
52W Low$0.6
Raffles Medical Group Ltd (RAFLF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
RAFLF · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 23, 2026EPS Actual
$0.02
Revenue
$0.30B
Est. $0.21B · +43.7%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 23, 2026
After Market Close
▲ Beat Revenue
RAFLF reports quarterly as a OTC-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 3, 2026 | — | — | — | — | — | — |
| — Q1 FY2026 | Feb 23, 2026 | — | $0.02 | — | $0.30B | $0.21B | +43.7% |
| — Q3 FY2025 | Jul 28, 2025 | — | $0.01 | — | $0.30B | $0.32B | -5.9% |
| ◌ Q2 FY2025 | Apr 25, 2025 | — | — | — | — | — | — |
| — Q1 FY2025 | Feb 23, 2025 | — | $0.01 | — | $0.28B | — | — |
| — Q3 FY2024 | Jul 29, 2024 | — | $0.01 | — | $0.18B | — | — |
| — Q2 FY2024 | Apr 26, 2024 | — | $0.01 | — | $0.18B | — | — |
| — Q1 FY2024 | Feb 26, 2024 | — | $0.01 | — | $0.17B | — | — |
Q3 FY2026
Aug 3, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 23, 2026
EPS Actual
$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.30B
Q3 FY2025
Jul 28, 2025
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.30B
Q2 FY2025
Apr 25, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Feb 23, 2025
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.28B
Q3 FY2024
Jul 29, 2024
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.18B
Q2 FY2024
Apr 26, 2024
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.18B
Q1 FY2024
Feb 26, 2024
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.17B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.01 | $0.01 | $0.01 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2028 | $0.4B | $0.4B | $0.4B | 1 |
| Q1 FY2028 | $0.4B | $0.4B | $0.4B | 1 |
| Q4 FY2027 | $0.4B | $0.4B | $0.4B | 1 |
| Q1 FY2026 | $0.3B | $0.3B | $0.3B | 1 |
| Q4 FY2025 | $0.3B | $0.3B | $0.3B | 1 |
| Q3 FY2025 | $0.3B | $0.3B | $0.3B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Feb 23, 2026 | — | $0.74 | $0.74 | +0.00% |
| — Q3 FY2025 | Jul 28, 2025 | — | $0.81 | $0.81 | +0.33% |
| — Q1 FY2025 | Feb 23, 2025 | — | $0.60 | $0.60 | +0.00% |
| — Q3 FY2024 | Jul 29, 2024 | — | $0.74 | $0.74 | +0.00% |
| — Q2 FY2024 | Apr 26, 2024 | — | $0.74 | $0.74 | +0.00% |
| — Q1 FY2024 | Feb 26, 2024 | — | $0.73 | $0.74 | +1.58% |
| — Q4 FY2023 | Dec 30, 2023 | — | $0.77 | $0.77 | +0.00% |
| — Q2 FY2023 | Jun 29, 2023 | — | $1.08 | $1.08 | +0.00% |
Q1 FY2026+0.00%
Report Date
Feb 23, 2026
EPS Beat/Miss
—
Price Before
$0.74
Price After
$0.74
Q3 FY2025+0.33%
Report Date
Jul 28, 2025
EPS Beat/Miss
—
Price Before
$0.81
Price After
$0.81
Q1 FY2025+0.00%
Report Date
Feb 23, 2025
EPS Beat/Miss
—
Price Before
$0.60
Price After
$0.60
Q3 FY2024+0.00%
Report Date
Jul 29, 2024
EPS Beat/Miss
—
Price Before
$0.74
Price After
$0.74
Q2 FY2024+0.00%
Report Date
Apr 26, 2024
EPS Beat/Miss
—
Price Before
$0.74
Price After
$0.74
Q1 FY2024+1.58%
Report Date
Feb 26, 2024
EPS Beat/Miss
—
Price Before
$0.73
Price After
$0.74
Q4 FY2023+0.00%
Report Date
Dec 30, 2023
EPS Beat/Miss
—
Price Before
$0.77
Price After
$0.77
Q2 FY2023+0.00%
Report Date
Jun 29, 2023
EPS Beat/Miss
—
Price Before
$1.08
Price After
$1.08
Beat Rate0 / 8 quarters
Largest Move+1.58% (Q1 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: RAFLF ends December
Raffles Medical Group Ltd (RAFLF) most recently reported earnings on February 23, 2026 for Q1 FY2026, posting EPS of $0.02 (in line with the analyst consensus of —). The next RAFLF earnings date is expected around September 1, 2026.
Each quarter, investors track RAFLF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. RAFLF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
RAFLF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
RAFLF earnings · 4 questionsRaffles Medical Group Ltd's next earnings report is expected around September 1, 2026. RAFLF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; RAFLF historically reports after market close (AMC).
RAFLF earnings datewhen is RAFLF earningsRAFLF next earnings datewhen does RAFLF report earningsRAFLF earnings calendar
▸ Source: FMP · Raffles Medical Group Ltd SEC filings · US GAAP · Raffles Medical Group Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026